4//SEC Filing
Morris David J 4
Accession 0001181431-10-063681
CIK 0001295976other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:25 PM ET
Size
10.1 KB
Accession
0001181431-10-063681
Insider Transaction Report
Form 4
Morris David J
Sr. V.P. Finance, CFO
Transactions
- Disposition to Issuer
Common Stock
2010-12-27$12.00/sh−92,395$1,108,740→ 0 total - Disposition to Issuer
Employee Stock Option
2010-12-27−28,225→ 0 totalExercise: $11.45Exp: 2020-01-27→ Common Stock (28,225 underlying) - Disposition to Issuer
Employee Stock Option
2010-12-27−120,932→ 0 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (120,932 underlying)
Footnotes (2)
- [F1]On December 27, 2010, a wholly owned subsidiary of Clearwater Paper Corporation merged with Cellu Tissue Holdings, Inc. pursuant to a merger agreement entered into between Clearwater Paper and Cellu Tissue on September 15, 2010 (the "Merger"), as more fully described in the Cellu Tissue proxy statement dated December 1, 2010 filed with the SEC. Each share of common stock of Cellu Tissue was converted into $12.00 in cash. Cellu Tissue board approved the disposition by the Reporting Person in the Merger.
- [F2]In connection with the Merger, each outstanding Cellu Tissue option to purchase shares of common stock, whether or not vested, was cancelled and Reporting Person received a cash payment in an amount equal to the number of shares of common stock represented by each option, vested or unvested, multiplied by the excess, if any, of $12.00 over the exercise price per share under each option. Reporting Person's disposition of options in the Merger was approved by the Cellu Tissue board of directors.
Documents
Issuer
Cellu Tissue Holdings, Inc.
CIK 0001295976
Entity typeother
Related Parties
1- filerCIK 0001306780
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 7:25 PM ET
- Size
- 10.1 KB